| Breast Cancer |
1 |
1 |
| Triple Negative Breast Cancer |
0 |
0.7 |
| Cancer |
0 |
0.61 |
| Breast |
0 |
0.56 |
| Cancer Risk |
0 |
0.55 |
| Genomic Medicine |
0 |
0.55 |
| Endometrial Cancer |
0 |
0.54 |
| Selective Estrogen Receptor Modulators |
0 |
0.46 |
| Lobular Carcinoma |
0 |
0.45 |
| Breastfeeding |
0 |
0.41 |
| Uterine Cancer |
0 |
0.39 |
| Chemoprophylaxis |
0 |
0.3 |
| Estrogen |
0 |
0.23 |
| Patient Safety |
0 |
0.2 |
| Adverse Effects |
0 |
0.18 |
| Pregnancy |
0 |
0.14 |
| Thrombus |
0 |
0.13 |
| Obesity |
0 |
0.12 |
| Thromboembolism |
0 |
0.12 |
| Biopsy |
0 |
0.09 |
| Blood |
0 |
0.09 |
| Cardiovascular Risk Management |
0 |
0.09 |
| Genetics |
0 |
0.09 |
| Vagina |
0 |
0.09 |
| Genetic Testing |
0 |
0.08 |
| Vaginal Discharge |
0 |
0.08 |
| Aromatase Inhibitors |
0 |
0.07 |
| Receptors |
0 |
0.07 |
| Uterus |
0 |
0.07 |
| Cerebrovascular Accident |
0 |
0.05 |
| Tobacco Cessation |
0 |
0.05 |
| Body Mass Index |
0 |
0.04 |
| Bone |
0 |
0.04 |
| Contraception |
0 |
0.04 |
| Exercise |
0 |
0.04 |
| Night Sweats |
0 |
0.04 |
| Smoking |
0 |
0.04 |
| Tissue |
0 |
0.04 |
| Adrenal Gland |
0 |
0.03 |
| Depression |
0 |
0.03 |
| Menopause |
0 |
0.03 |
| Osteoporosis |
0 |
0.03 |
| Sterilization, Birth Control |
0 |
0.03 |
| Washington DC |
0 |
0.03 |
| Weight Management |
0 |
0.03 |
| Antidepressant drug |
0 |
0.02 |
| Arthralgia |
0 |
0.02 |
| Birth |
0 |
0.02 |
| Diet |
0 |
0.02 |
| Dorsum |
0 |
0.02 |
| Gland |
0 |
0.02 |
| Hair |
0 |
0.02 |
| Heart |
0 |
0.02 |
| Ovary |
0 |
0.02 |
| Primary Care |
0 |
0.02 |
| Referral |
0 |
0.02 |
| Risk Management |
0 |
0.02 |
| Transient Ischemic Attack |
0 |
0.02 |
| Washington |
0 |
0.02 |
| Weight Loss |
0 |
0.02 |